We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > News > Science & Health > Content Piece

Patents Secured for Promising Cannabinoid Pain-patch

Published: May 09, 2018   

Credit: Pxhere

Listen with
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.

Cannabis Leaf has announced that they have secured the IP rights for Pain Patch, Apotheca Biosciences’ pain alleviation technology.

Apotheca has been developing Pain-Patch using CannaDERME transdermal delivery and state-of-the art smart device technologies for relieving various pains. Apotheca has formulated cannabidiol-based Pain-Patch for proof-of-concept studies. The company has now secured the two patent rights for this novel device which encompasses CannaDERME™ transdermal formulation and Pain-patch medical device technologies.

• Cannabidiol is one of the key cannabinoid constituents of the Hemp Plant. CBD is non-psychoactive and safe compound with a wide range of therapeutic applications, including the treatment of neural disorders and clinical studies have suggested a wide range of possible therapeutic effects of cannabidiol on several conditions.

• The Pain-Patch has transcutaneous cannabinoid penetration technology coupled with thermosensitive nano-emulsion for sustained release of compounds for longer time. The device delivers therapeutic doses to brain via brain stem for whole-body effect.

• The goal of these patches are to produce a pain-patch with a small footprint for easy concealment, a strong formula to counteract the decreased quality of life for individuals who suffer with systemic pain, a long shelf-life and the use of non-toxic and non-abrasive components to create the most comfortable and effective patch on the market using this technology.

• Apotheca is partnering up with pain management physician and opioid addiction centers groups for conducting clinical studies using Pain-Patch for various kinds of chronic pain and addiction.         

“We shared our pain-patch with leading pain doctors in the region and they were all excited”; Preliminary studies on pain-patch shows excellent results” said Bobban Subhadra, M.S., Ph.D, Chief Operating Officer of Apotheca. “We are securing the IP rights and partnering with more pain doctors to get their valuable clinical feedback” he added.

This article has been republished from materials provided by Apotheca Biosciences. Note: material may have been edited for length and content. For further information, please contact the cited source.


Like what you just read? You can find similar content on the topic tag shown below.

Science & Health

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter